PRKAA1 and hepatocellular carcinoma: Nilotinib, a second-generation tyrosinase kinase inhibitor used for treating leukemia, and AZD8055, an inhibitor of mTORC1 and mTORC2, also induced autophagic cell death in HCC cells by activating AMPK signaling but showed no effect on apoptosis [60,69].